Skip to content

13F-HR filed by TRV GP IV, LLC

TRV GP IV, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-10, with 5 holding rows worth $272,967,000.

Accession
0000950123-22-005022
Filed
2022-05-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 5 entries on the cover page, a total value of $272,967,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $272,967,000 with VALUE read as thousands by filing date, 13F file number 028-18982. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TANGO THERAPEUTICS INC87583X109COM19,363,975$146,779,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK2,343,154$55,416,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock1,419,900$36,222,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock6,758,204$19,599,000thousands by filing date
PLIANT THERAPEUTICS INC729139105COM2,132,867$14,951,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-22-005022this filing2022-05-10acceptance time not in the bulk data set